Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers.
about
GABAergic interneuron origin of schizophrenia pathophysiology.Functional neuroimaging in psychiatryImpact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.Ketamine for treatment-resistant unipolar depression: current evidenceExcitation-inhibition discoordination in rodent models of mental disorders.Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal studyPreliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjectsChronic ketamine exposure induces permanent impairment of brain functions in adolescent cynomolgus monkeysActivation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake ratsThe expression of genes involved in glucose metabolism is affected by N-methyl-D-aspartate receptor antagonism: a putative link between metabolism and an animal model of psychosisAmphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunctionDysfunctional GABAergic inhibition in the prefrontal cortex leading to "psychotic" hyperactivationNegative visuospatial priming in isolation-reared rats: Evidence of resistance to the disruptive effects of amphetamine.Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.The electrophysiological signature of motivational salience in mice and implications for schizophrenia.Differential role of NR2A and NR2B subunits in N-methyl-D-aspartate receptor antagonist-induced aberrant cortical gamma oscillations.Modulation of sensorimotor gating in prepulse inhibition by conditional brain glycine transporter 1 deletion in miceBrain mechanisms of hallucinogens and entactogens.Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia.Biology and recent brain imaging studies in affective psychoses.Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects.Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes.Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.The interactive effects of ketamine and nicotine on human cerebral blood flowDisruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophreniaNMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.Ketamine use: a review.NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex.Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeuticsThe recruitment of normal healthy volunteers: a review of the literature on the use of financial incentives.Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments.From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.Effects of Chronic D-Serine Elevation on Animal Models of Depression and Anxiety-Related BehaviorGlutamatergic model psychoses: prediction error, learning, and inferenceThe antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS.In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5.Early-course unmedicated schizophrenia patients exhibit elevated prefrontal connectivity associated with longitudinal change.Role of Thalamic Projection in NMDA Receptor-Induced Disruption of Cortical Slow Oscillation and Short-Term Plasticity.Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.Ketamine administration in healthy volunteers reproduces aberrant agency experiences associated with schizophrenia.
P2860
Q24597790-8087DB7F-1446-424E-B7B4-61E99BFFAB53Q24676567-B2C32732-048B-482A-AE7D-327B6E0B95C7Q26830533-1995D77A-43BB-4E51-BF19-115402A0E09DQ27004508-E8B65FBB-CB4B-494E-A030-D8A76689CEE6Q27692087-595E514D-3A96-4F66-AF0E-6E9714AE4E06Q28264991-1B1F69D3-516E-468A-B8DA-4BA4D3EF1279Q28276986-BEDDB47F-9083-4275-B7D4-077F13C31653Q28279105-C1E9E1F4-CB6A-4863-A771-8DD015054E32Q28297687-D1279EEE-D4DC-40B4-9D00-113034F54289Q28574077-2FF8E65A-0EB0-4860-8092-5E7CF0B18904Q28590145-61CB2A09-EA23-4141-A1C1-88D97B0AB41BQ28754545-F72DC245-E31C-47AF-B0C2-D10BD26049EDQ30368568-6849A435-3585-46FB-9ACD-DDF4477710D7Q30403787-0DE5640B-B261-45FD-92F3-209C4AB9C431Q30446683-99BF7CA9-7EE0-491B-84AC-6DDDA127EF1EQ30453949-128BCE02-DCC5-438D-96A1-7DB7D568AFCEQ30468003-C288C687-353F-4FBC-9D31-7D35EFCD0AA4Q30473430-BE87216D-DFE7-4856-8DE2-578DBE209C5CQ30483032-3AE7D5BF-C961-4189-9B0F-881677AC3505Q30621010-F00B6F52-7D5A-4DA8-872D-35BD265478C9Q30841490-26B11DDC-E5B1-4A7E-902A-B1D16EABA133Q33556077-BDCBC21B-EAAC-4342-A582-62433FB3495AQ33604654-711895AF-95B5-44F4-AD9F-861517602206Q33937889-978D6B8F-CCFB-4B14-B897-41023B4E2400Q33976994-BA40B57C-4A64-40A2-A00E-0983C6FAA8C8Q34197064-255B99BD-0924-4E78-8D47-20EFED52FC44Q34202404-3D6DC6A4-6B8D-4991-90B7-6E5DABD15A98Q34376159-AB6C17F2-9A32-4EA9-8145-53DD02C84B7EQ34444632-36A9A7FA-BED7-4DC9-8F68-1B8D268BF5FAQ34590430-6FBF98A9-8BFE-46E8-86FA-F394749DACCEQ34622392-FF98B4A0-CBC2-4F98-B80B-36D9670534EDQ34632695-53D7A19D-C084-41CB-A707-198721655E18Q34653628-2E5A9179-8EC2-4434-8E29-62DED72894E0Q34661231-303CD687-A78C-4FD8-BE5F-C75E07897A0AQ34702471-A796267A-C918-4928-9B2B-375F635AE354Q34778858-F3369FE4-DFA1-4B11-9CA5-681CE8F88D12Q34869701-6F629C0C-759D-48DB-903B-6AA6CAC12A4DQ34953049-A979400C-90CA-41D3-AB57-7883424EF769Q35027572-81705B43-DB58-47E6-A30C-73B17EBF996FQ35130393-018A47A4-C923-40C6-8C39-66173950B2C2
P2860
Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Association of ketamine-induce ...... cortex in healthy volunteers.
@ast
Association of ketamine-induce ...... cortex in healthy volunteers.
@en
Association of ketamine-induce ...... cortex in healthy volunteers.
@nl
type
label
Association of ketamine-induce ...... cortex in healthy volunteers.
@ast
Association of ketamine-induce ...... cortex in healthy volunteers.
@en
Association of ketamine-induce ...... cortex in healthy volunteers.
@nl
prefLabel
Association of ketamine-induce ...... cortex in healthy volunteers.
@ast
Association of ketamine-induce ...... cortex in healthy volunteers.
@en
Association of ketamine-induce ...... cortex in healthy volunteers.
@nl
P2093
P356
P1476
Association of ketamine-induce ...... cortex in healthy volunteers.
@en
P2093
Malhotra AK
Weisenfeld NI
P304
P356
10.1176/AJP.154.6.805
P407
P577
1997-06-01T00:00:00Z